Washington DC DC

Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On

WAMU Radio Washington

Oct 27, 2020

Eli Lilly & Co. is ending a clinical trial of its antibody drug bamlanivimab in hospitalized COVID-19 patients after federal researchers concluded the therapy produced no marked im…

Read the full story at WAMU Radio Washington

Topics

#Coronavirus #Eli Lilly

Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On

Topics

More from Washington DC

No Kings rallies across U.S. urge voters to cast ballots early ahead of midterms

Cat dies in accidental fire in Southeast Washington, DC row house

Hoyas Win Open Atlantic Coast Championship Round 1 and MAISA Match Race Title

La Plata shooting leaves man critically injured early Saturday

Justice Department asks judge to step aside in East Potomac Golf Links lawsuit

Georgetown triumphs over GW men's basketball in second consecutive DC rivalry game

DC looks at menu of possible tax increases in tight budget year

Death of missing DC man ruled homicide months after remains found